Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

Risk of heart failure (HF) has been shown to increase as body mass index (BMI) increases; however, BMI has limitations as an obesity measure. Over median follow-up of 13 years, waist-to-height ratio ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Three notes: The overall incidence of obesity-related cancers was similar between the GLP-1 and bariatric surgery groups — about 5 to 6 cases per 1,000 person-years — despite the fact that ...

US News has weighed in on America’s ever-expanding waistline, ranking the country’s most obese states — and the results may ...

Studies have shown that bariatric surgery reduces the incidence of obesity-related cancers. A recent study established to determine if GLP-1 receptor agonists can reduce the risk of developing obesity ...

Queen Latifah wants the world to know obesity is a disease, one often tainted with stigma. The Grammy Award-winning musician and actress opened up about the public awareness campaign, Truth About ...

retrospective cohort study based on electronic medical records data to compare the incidence of ORC in adults (≥24 years) living with obesity and diabetes who were treated with a first ...